Thymogen
Overview
Research-use synthetic dipeptide supplied for studies of T-cell differentiation, thymic signaling, and cytokine pathway models.
- Concentration
- 20 mg
- Stock
- In stock
Product details
Thymogen is a synthetic Glu-Trp dipeptide used in research models of thymic signaling and immune pathway regulation. Pattern lists this material for controlled laboratory research.
Research Targets: T-cell receptor signaling, cytokine receptor pathways, thymic stromal interaction models, lymphocyte maturation systems.
Key Feature: Short thymic-derived dipeptide format for immune signaling research.
Research Focus Areas: T-cell maturation, cytokine balance, thymic axis function, immune restoration pathway models.
Common Models: Lymphocyte proliferation assays, cytokine secretion studies, immunosuppression models, aging immune models.
Mechanistic Interests: T-lymphocyte differentiation markers, IL-2 and interferon pathway modulation, thymic peptide signaling, cellular immunity markers.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- Glu-Trp / Oglufanide Immunomodulatory Dipeptide
- Composition
- Synthetic dipeptide composed of L-glutamic acid and L-tryptophan (L-Glu-L-Trp), also known as oglufanide or glutamyltryptophan
- Discovery
- Developed from thymic peptide research; Glu-Trp was isolated from thymic preparations and later synthesized as Thymogen
- Research scope
- Evidence includes in vitro immune-cell/cytokine studies, animal models, Russian clinical literature, and drug-development references to oglufanide; broad Western clinical validation is limited
- Regulatory status
- Research-only or region-specific pharmaceutical status depending on jurisdiction
Safety context
- Known hypersensitivity to Glu-Trp products
- Use caution in autoimmune disease, active malignancy, transplant status, or immunosuppressive therapy
- Pregnancy and breastfeeding due to insufficient safety data
Research-use notice: Thymogen/Glu-Trp is an immunomodulatory dipeptide with regional pharmaceutical history and published preclinical/in vitro support, but it is not FDA-approved and lacks broad contemporary validation for most research/wellness uses. Immune-active compounds should be used only with qualified medical oversight.
Full guide includes 10 reference entries.
One kit adds 10 vials to checkout.